[Clinico-pathological and molecular aspects of diagnostic and prognostic value in gliomas].

[Clinico-pathological and molecular aspects of diagnostic and prognostic value in gliomas].

CONCLUSIONS. The study of proteomics and molecular biomarkers should complement the histopathological analysis and sometimes allows to determine direct or indirect predictive factors as well as the study of affected pathways which may become selective therapeutic targets. PMID: 23359078 [PubMed - in process] (Source: Revista de Neurologia) View Source